TibaRay develops ultra-fast and ultra-precise technology aimed at improving radiotherapy for cancer treatment. Self-described as a significant technological advancement in the field.

TibaRay, Inc

TibaRay

TibaRay develops ultra-fast and ultra-precise technology for cancer radiotherapy. It aims to improve treatment effectiveness and reduce collateral damage to normal tissues, self-described as a significant technological advancement in the field.

TibaRay, Inc | 463 followers on LinkedIn. Bring the hope of cure to patients with cancer worldwide by creating revolutionary, ultra-fast, ultra-precise technology | TibaRay, Inc. is a dynamic, Bay Area startup developing the next generation particle-accelerator-based system for treating cancer.

Rebecca Fahrig

Jeff Amacker

President & CEO of Gonsalves & Stronck Construction Company, Inc. Emerging Tech Investor

William Stronck

PhD in Physics

Gerard Lawler

🌟 We’re thrilled to announce that our CEO Jeff Amacker has been invited to present TibaRay, Inc and our groundbreaking PHASER technology at the #LSIEurope24 : Emerging Medtech Summit from September 16th to 20th in Sintra, Portugal! TibaRay is developing a Radiation Therapy device that will Cure Cancer in a FLASH! LSI is a premier event, where industry visionaries, thought leaders, and professionals come together to shape the future of Medtech. 🚀 #LSIEUROPE24 #LSIalumni #medtech #radiationtherapy #fundraising Kelly Williams Blake Matrone

Following the announcement of our groundbreaking partnership with Leo Cancer Care our CEOs sat down at #PTCOG62 . Jeff Amacker and Stephen Towe discuss the cutting-edge technology and vision behind this transformative project. This collaboration promises to revolutionize radiation therapy, enhancing patient comfort and treatment effectiveness. Stay tuned for more updates as we embark on this journey to improve patient care and advance medical technology! Watch the full interview here: https://lnkd.in/eU4tG5tF #HealthcareInnovation #RadiationTherapy #Partnership #MedicalTechnology #PatientCare

Bill Loo , Board Member and co Founder talks about the benefits of #FLASH and #Upright #Radiotherapy at The 62nd Particle Therapy Co-Operative Group Conference in #Singapore #PTCOG62 . We are excited about our partnership with Leo Cancer Care and the development of this novel technology. https://lnkd.in/e5zhCM5k

Exciting news! Our company profile is now live on Fundable ! TibaRay is featured in the "New and Noteworthy" section, ensuring optimal visibility for their investor audience. We have been given the go ahead with sharing our profile with our network using the following link: https://lnkd.in/eTTRfEuj #funding #radiationtherapy #fundraising

We are beyond excited to share the unique partnership agreement signed with upright radiotherapy specialists Leo Cancer Care that will see the development of a first-of-its-kind upright linear accelerator. We are joining forces to develop a solution for photon therapy combining TibaRay’s linear accelerator (linac) technology with Leo Cancer Care’s upright patient positioning* and imaging system. The proposed partnership would involve using TibaRay’s efficient X-ray generation system as part of Leo’s future upright photon therapy solutions. CEO Jeff Amacker said: “This collaboration aims to leverage the technological strengths of both companies to jointly develop innovative new products that will set new industry standards in Radiation Therapy and drive growth for our organisations. “TibaRay has breakthrough technology and know-how in X-ray generation and Radiation Therapy systems and we have been impressed with Leo Cancer Care’s expertise in upright radiotherapy solutions. “By combining our respective strengths, we believe we can create unique products that will change the face of Radiation Therapy for good and bring hope of cure to patients with cancer globally. This is a shared vision of both TibaRay and Leo Cancer Care that we are excited to realize together.” Leo Cancer Care CEO Stephen Towe said: “Collaborations such as this illustrate how our simple shift from machine rotation to patient rotation provides a platform for new and innovative modalities. We believe our solutions firmly belong in the future of cancer care, working with our friends TibaRay the future of upright radiotherapy looks even brighter.” With the agreement, the companies have a product development roadmap and will work closely and cohesively to deliver better treatment options to patients. Leo Board Chairman Thomas (Rock) Mackie , who as a long-standing innovator in the world of radiation technology, played a pivotal role in forging the partnership, added: "Leo Cancer Care is looking forward to offering the advantages of the TibaRay accelerator. The TibaRay accelerator will deliver a higher photon beam output in a more compact footprint combined with faster upright position setup times. This will facilitate a more human patient experience and improve patient access to care.” Founder and Board Director, Bill Loo , a physician-scientist Radiation Oncologist and Bioengineer, and Director of Thoracic Radiation Oncology and New Technologies at Stanford Cancer Institute , added: “The novel combination of technologies enabling extremely rapid dose delivery and upright patient positioning promises not only a leap in precision targeted radiotherapy for cancer, but also better accessibility and clinical efficiency of curative cancer treatment for patients worldwide.” #radiationtherapy #uprightlinearaccelerator #collaboration

TibaRay, Inc is on a mission to cure cancer with its technology. Supported by Keiretsu Forum Members, they’re showcasing at the Angel Capital Association Summit. Come see how we're backing solutions that promise a better tomorrow.

Howard Lubert

Excited to share that TibaRay has been invited to pitch at Keiretsu Forum London on Monday 29th of April. CEO Jeff Amacker will be presenting the opportunity to invest in our Radiation Therapy device. TibaRay is presenting among 2 other companies MatLogica and Biostress and TO THE MARKET (Keiretsu portfolio company) will be sharing their exciting progress.

🌟We are excited and proud to share the founders of TibaRay🌟 Rebecca Fahrig PhD Head of Business Line EVR (Endovascular Robotics) for Business Area Advanced Therapies, Siemens Healthineers World expert in medical imaging physics Former Professor of Radiology, Stanford University Peter G Maxim, PhD Professor & Vice Chair, Radiation Oncology, UC Irvine World expert in medical physics, image-guided radiotherapy Bill Loo MD PhD Professor of Radiation Oncology, Stanford University World expert in lung cancer, stereotactic ablative radiotherapy, FLASH radiobiology Sami Tantawi PhD Professor of Particle Physics & Astrophysics, Stanford University Chief Scientist, Accelerator Technology Research, SLAC National Accelerator Laboratory World expert in accelerator and RF science

Pleased to share that CEO Jeff Amacker has been invited to Keiretsu Forum Mid-Atlantic virtual event tomorrow 4/17 to present TibaRay, Inc and our progress to date. Keiretsu Forum Mid-Atlantic TibaRay is developing a Radiation Therapy device that will Cure Cancer in a FLASH! Having completed the investors due diligence with Keiretsu Forum Midwest and currently raising Series A funds to continue development of Phaser! If interested to know more reach out to CEO @Jeff Amacker! #radiationtherapy #flashRT #curecancer #fundraising #seriesA Sotiris Pagdadis, Ph.D. Howard Lubert https://lnkd.in/dTRUJRXd

Very informative article on FLASH RT by the Oncology Nurse Advisor , and pleased to say TibaRay's PHASER overcomes all challenges mentioned in the article! TibaRay is developing eXactFLASH: Sub-second FLASH treatment Exquisite dose sculpting Anywhere in the body Easy adoption Fits in existing vaults Existing workflow Existing reimbursement codes > 2x patients #radiotherapy #flashrt #oncology #fundraising #SeriesA https://lnkd.in/gn8RSkbJ

COM:TIBARAY

TibaRay

locale

market

industry

website

crunchbase

linkedin

peer of

competitor of

Metrics